Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6532)
All Articles published online
|
Publishing Process of This Article
|
Oct 15, 2015 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Takai E, Yachida S. Genomic alterations in pancreatic cancer and their relevance to therapy. World J Gastrointest Oncol 2015; 7(10): 250-258 [PMID: 26483879 DOI: 10.4251/wjgo.v7.i10.250] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v7/i10/250.htm |
| Number | Citing Articles |
| 1 |
Cheng Xiong, Youwei Zhu, Meilin Xue, Yongsheng Jiang, Yiming Zhong, Lingxi Jiang, Minmin Shi, Hao Chen. Tumor-associated macrophages promote pancreatic ductal adenocarcinoma progression by inducing epithelial-to-mesenchymal transition. Aging 2021; 13(3): 3386 doi: 10.18632/aging.202264
|
| 2 |
Qingyun Zhu, Xinting Pan, Yunbo Sun, Zhengbin Wang, Fuguo Liu, Aiqin Li, Zhihui Zhao, Yunlong Wang, Kun Li, Liangyu Mi, Jose G. Trevino. Biological nanoparticles carrying the Hmda-7 gene are effective in inhibiting pancreatic cancer in vitro and in vivo. PLOS ONE 2017; 12(10): e0185507 doi: 10.1371/journal.pone.0185507
|
| 3 |
Robin Imperial, Omer M Toor, Arif Hussain, Janakiraman Subramanian, Ashiq Masood. Comprehensive pancancer genomic analysis reveals (RTK)-RAS-RAF-MEK as a key dysregulated pathway in cancer: Its clinical implications. Seminars in Cancer Biology 2019; 54: 14 doi: 10.1016/j.semcancer.2017.11.016
|
| 4 |
Claudio Luchini, Paola Capelli, Aldo Scarpa. Pancreatic Ductal Adenocarcinoma and Its Variants. Surgical Pathology Clinics 2016; 9(4): 547 doi: 10.1016/j.path.2016.05.003
|
| 5 |
Shuangshuang Lu, Tasqeen Ahmed, Pan Du, Yaohe Wang. Genomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment. International Journal of Molecular Sciences 2017; 18(6): 1201 doi: 10.3390/ijms18061201
|
| 6 |
Enza Vernucci, Jaime Abrego, Venugopal Gunda, Surendra K. Shukla, Aneesha Dasgupta, Vikrant Rai, Nina Chaika, Kyla Buettner, Alysha Illies, Fang Yu, Audrey J. Lazenby, Benjamin J. Swanson, Pankaj K. Singh. Metabolic Alterations in Pancreatic Cancer Progression. Cancers 2019; 12(1): 2 doi: 10.3390/cancers12010002
|
| 7 |
Michele Masetti, Giorgia Acquaviva, Michela Visani, Giovanni Tallini, Adele Fornelli, Moira Ragazzi, Francesco Vasuri, Daniela Grifoni, Simone Di Giacomo, Sirio Fiorino, Raffaele Lombardi, David Tuminati, Matteo Ravaioli, Carlo Fabbri, Maria Letizia Bacchi-Reggiani, Annalisa Pession, Elio Jovine, Dario de Biase. Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4. Cancer Biomarkers 2018; 21(2): 323 doi: 10.3233/CBM-170464
|
| 8 |
Cristoforo Grasso, Gerrit Jansen, Elisa Giovannetti. Drug resistance in pancreatic cancer: Impact of altered energy metabolism. Critical Reviews in Oncology/Hematology 2017; 114: 139 doi: 10.1016/j.critrevonc.2017.03.026
|
| 9 |
Robert Matera, Muhammad Wasif Saif. New therapeutic directions for advanced pancreatic cancer: cell cycle inhibitors, stromal modifiers and conjugated therapies. Expert Opinion on Emerging Drugs 2017; 22(3): 223 doi: 10.1080/14728214.2017.1362388
|
| 10 |
Jana Tarabay, Xiaodong Li, Vishal S. Chandan. Adenosquamous carcinoma of the pancreas. Clinics and Research in Hepatology and Gastroenterology 2020; 44(6): 796 doi: 10.1016/j.clinre.2020.01.008
|
| 11 |
Sara Calistri, Giuseppe Ottaviano, Alberto Ubaldini. Radiopharmaceuticals for Pancreatic Cancer: A Review of Current Approaches and Future Directions. Pharmaceuticals 2024; 17(10): 1314 doi: 10.3390/ph17101314
|
| 12 |
Soon-Chan Kim, Young-Kyoung Shin, Sun-Whe Kim, Ha-Young Seo, Wooil Kwon, Hongbeom Kim, Youngmin Han, Ja-Oh Lee, Jin-Young Jang, Ja-Lok Ku. Establishment and Characterization of 10 Human Pancreatic Cancer Cell Lines Including a HER2 Overexpressed Cell Line. Pancreas 2019; 48(10): 1285 doi: 10.1097/MPA.0000000000001420
|
| 13 |
Marwa Alhothali, Mevin Mathew, Geeta Iyer, Harshani R. Lawrence, Shengyu Yang, Srikumar Chellappan, Jaya Padmanabhan. Fendiline Enhances the Cytotoxic Effects of Therapeutic Agents on PDAC Cells by Inhibiting Tumor-Promoting Signaling Events: A Potential Strategy to Combat PDAC. International Journal of Molecular Sciences 2019; 20(10): 2423 doi: 10.3390/ijms20102423
|
| 14 |
Matteo Giulietti, Giulia Occhipinti, Giovanni Principato, Francesco Piva. Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development. Cellular Oncology 2016; 39(4): 379 doi: 10.1007/s13402-016-0283-7
|
| 15 |
Deepanshi Dhar, Komal Raina, Dileep Kumar, Michael F. Wempe, Stacey M. Bagby, Todd M. Pitts, David J. Orlicky, Chapla Agarwal, Wells A. Messersmith, Rajesh Agarwal. Bitter melon juice intake with gemcitabine intervention circumvents resistance to gemcitabine in pancreatic patient‐derived xenograft tumors. Molecular Carcinogenesis 2020; 59(10): 1227 doi: 10.1002/mc.23251
|
| 16 |
Çiğdem Usul Afsar, Mehmet Karabulut, Senem Karabulut, Halil Alis, Murat Gonenc, Nergiz Dagoglu, Murat Serilmez, Faruk Tas. Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma. Journal of Infection and Chemotherapy 2017; 23(4): 196 doi: 10.1016/j.jiac.2016.12.003
|
| 17 |
Angelyn V. Nguyen, Brittany Trompetto, Xing Haw Marvin Tan, Michael B. Scott, Kenneth Hsueh-heng Hu, Eric Deeds, Manish J. Butte, Pei Yu Chiou, Amy C. Rowat. Differential Contributions of Actin and Myosin to the Physical Phenotypes and Invasion of Pancreatic Cancer Cells. Cellular and Molecular Bioengineering 2020; 13(1): 27 doi: 10.1007/s12195-019-00603-1
|
| 18 |
Soumaya Menadi, Burak Kucuk, Ercan Cacan. Promoter Hypomethylation Upregulates ANXA2 Expression in Pancreatic Cancer and is Associated with Poor Prognosis. Biochemical Genetics 2024; 62(4): 2721 doi: 10.1007/s10528-023-10577-5
|